Ethics of Continuing to Provide a Drug on an Open-Label Extension Study for an “Unapproved Indication”

American Journal of Bioethics 14 (4):56-56 (2014)
  Copy   BIBTEX

Abstract

No abstract

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 100,865

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Open-Label Extension Studies: Are They Really Research?Mildred K. Cho - 2014 - American Journal of Bioethics 14 (3):1-2.
When Should Open-Label Extension Studies Be Stopped?Joshua S. Crites - 2014 - American Journal of Bioethics 14 (4):57-58.
Consent to open label extension studies: some ethical issues.P. Wainwright - 2002 - Journal of Medical Ethics 28 (6):373-376.
Ethics Consultation: Data and the Path to Professionalization.Felicia Cohn - 2022 - American Journal of Bioethics 22 (4):1-4.

Analytics

Added to PP
2014-04-15

Downloads
32 (#703,717)

6 months
10 (#399,629)

Historical graph of downloads
How can I increase my downloads?